Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Chemical Information and Modeling|December 13, 2022
Comparison of Conformational Analyses of Naturally Occurring Flavonoid-<i>O</i>-Glycosides with Unnatural Flavonoid-CF<sub>2</sub>-Glycosides Using Molecular ModelingReem A Alkhodier, Sushil K Mishra, Robert J Doerksen, et al.Scientific Reports|December 11, 2025
Structure-based identification of compounds with potential as selective BLT1 antagonistsReem A Alkhodier, Saud A Alshamrani, Omar S Almutlaq, et al.Chemical Communications (Cambridge, England)|April 13, 2022
Generation of formaldehyde and formaldehyde-d<sub>2</sub> for hydroxymethylations and hydroxydeuteromethylations of difluoroenolates and difluorobenzyl carbanionsHari R Khatri, Changho Han, Reem A Alkhodier, et al.International Journal of Molecular Sciences|May 28, 2025
Correction: Al Subait et al. Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 736Arwa Al Subait, Raghad H Alghamdi, Rizwan Ali, et al.International Journal of Molecular Sciences|January 25, 2025
Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer CompoundsArwa Al Subait, Raghad H Alghamdi, Rizwan Ali, et al.International Journal of Molecular Sciences|July 12, 2025
Structure-Based Discovery of Orthosteric Non-Peptide GLP-1R Agonists via Integrated Virtual Screening and Molecular DynamicsMansour S Alturki, Reem A Alkhodier, Mohamed S Gomaa, et al.Frontiers in Chemistry|April 16, 2026
A multi-stage computational pipeline for repurposing FDA-approved drugs: application to EGFR C797S-mutant NSCLCMansour S Alturki, Reem A Alkhodier, Abdulaziz H Al Khzem, et al.Pageof 1